Skin Rash could Predict the Response to EGFR Tyrosine Kinase Inhibitor and the Prognosis for Patients with Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
OPEN PloS one | 6 Feb 2013
HB Liu, Y Wu, TF Lv, YW Yao, YY Xiao, DM Yuan and Y Song
The aim of this study was to assess the role of skin rash in predicting the efficacy of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) and the prognosis of patients with non-small cell lung cancer (NSCLC).
* Data courtesy of Altmetric.com